We engineer to higher standards inside a 503A facility, voluntarily, on every batch, regardless of size
Individuals with hair loss driven primarily by non-androgenetic causes, such as autoimmune alopecia, thyroid disorders, nutritional deficiencies, or medication side effects, may see limited benefit from CXXC5 inhibition specifically
Garvey has been a consultant on advisory boards for AbbVie, Allurion, Alnylam Pharmaceuticals, Boehringer Ingelheim, Carmot/Roche, Corcept, Eli Lilly, Fractyl Health, Gan & Lee, Inogen, Keros Therapeutics, MetSera, Neurocrine, Novo Nordisk, Pfizer, Regeneron, Terns Pharmaceuticals, and Zealand
While the Safe System approach represents a much-needed paradigm shift, it continues to grapple with a number of inherent contradictions, weaknesses and limitations